News Focus
News Focus
icon url

raja48185

01/31/22 2:09 PM

#347484 RE: Investor2014 #347470

I can understand that feeling of having butterflies in the stomach. The long delay only makes it worse (whatever be the reason)

For now, we can hope for the best; that the Rett results will be really good and robust enough (replicated) in adults, while being stellar in kids, given their age.

Let the results tell the story starting with Top Line Data
icon url

TTTav66

01/31/22 2:34 PM

#347493 RE: Investor2014 #347470

Fair enough, and I appreciate the reply. Personally, I tend to view the significant funding to be a rather prudent and timely move when facing the potential of a solo rare disease drug launch, but of course I can see how it could be viewed/utilized otherwise. I have no qualms with your 3 scenaris post, and appreciate maintaining a level approach. Cheers.
icon url

LakeshoreLeo1953

01/31/22 5:25 PM

#347566 RE: Investor2014 #347470

When combined with taking on the most significant additional funding ever before a key readout, that’s when I get a bit uneasy.



Many Corporate and Retail Balance sheets will likely show that locked
in funding LAST year will be beneficial.

IF Anavex turns out to be an entity with ulterior motives.....we ALL lose.